SCHEMBL4854071

SCHEMBL4854071

COc1ccc(OC)c(/C=C/C(=O)c2cccc(OCCN(C)C)c2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.60
PTPN1 P18031 2/20 0.56
LMNA P02545 2/20 0.55
MAPT P10636 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
KDM4E B2RXH2 2/20 0.55
ATM Q13315 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
PDE4A P27815 1/20 0.52
PDE4B Q07343 1/20 0.52
PDE4C Q08493 1/20 0.52
PDE4D Q08499 1/20 0.52
POLB P06746 1/20 0.52
ALDH1A1 P00352 3/20 0.52
KEAP1 Q14145 1/20 0.52
NFE2L2 Q16236 1/20 0.52
JUN P05412 1/20 0.51
NFKB1 P19838 1/20 0.51
BCHE P06276 2/20 0.51
NPC1 O15118 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4845314 1.00 ABCG2 (0.60) ABCG2PTPN1LMNAMAPTSMN1; SMN2
SCHEMBL4857305 0.95 ABCG2 (0.59) ABCG2PTPN1LMNAMAPTSMN1; SMN2
SCHEMBL4852947 0.95 ABCG2 (0.59) ABCG2PTPN1LMNAMAPTSMN1; SMN2
SCHEMBL4854815 0.92 MAPT (0.63) ABCG2PTPN1LMNAMAPTSMN1; SMN2
SCHEMBL4854108 0.92 MAPT (0.63) ABCG2PTPN1LMNAMAPTSMN1; SMN2
SCHEMBL4853601 0.89 KEAP1 (0.63) PTPN1LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL4848355 0.89 KEAP1 (0.63) PTPN1LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL4845561 0.89 ABCG2 (0.73) ABCG2PTPN1LMNAMAPTSMN1; SMN2
SCHEMBL4851382 0.87 ABCG2 (0.51) ABCG2PTPN1LMNAMAPTSMN1; SMN2
SCHEMBL4854277 0.87 MAPT (0.61) ABCG2PTPN1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed